查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1467967

人類增強市場：按類型、功能、最終用途分類 - 2024-2030 年全球預測

Human Augmentation Market by Type (Augmented Reality Device, Biometric System, Exoskeletons), Functionality (Body Worn, Non-Body Worn), End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年人類增強市場規模為2,558.4億美元，2024年將達2,962.4億美元，2030年將達7,214.4億美元，複合年成長率為15.96%。

人類增強涉及使用科技和各種手段來提高人體和心靈的能力和特徵。它涉及整合技術設備、植入和矯正器具等外部組件，以增強人類功能並超越人類的自然能力。人類增強技術包括身體增強、認知增強、感官增強和生物駭客等多種應用。提高認知和身體增強應用的意識和接受度是市場成長的催化劑。人類增強技術在軍事領域的不斷應用，以增強士兵的身體和認知能力，正在推動市場成長。由於缺乏有關人類增強技術的使用和應用的通用標準和指南，市場成長受到阻礙。此外，人類增強技術的研究、開發和最終應用相關的高成本正在阻礙市場成長。市場供應商在機器人、人工智慧和生物技術等領域的快速開拓將有助於創建更先進、更有效的人類增強設備和解決方案。預計這些將為市場成長創造機會。

主要市場統計
基準年[2023] 2558.4億美元
預測年份 [2024] 2962.4億美元
預測年份 [2030] 7214.4億美元
複合年成長率（%） 15.96%

擴大擴增實境設備的使用，以提供免持資料存取和導航指導

擴增實境(AR) 設備是穿戴式技術，可將數位資訊或虛擬物件疊加到實體世界上。它滿足了改善用戶體驗和生產力的需求。這些設備的需求量很大，因為它們可以提供免持資料存取和導航指導。指紋/虹膜掃描器和臉部辨識系統等生物辨識技術用於身份驗證和識別，因其便利性和安全性而受到青睞。生物辨識系統是一種根據生理或行為特徵驗證或確定活人身分的自動化方法。外骨骼是與人類能力互動的穿戴式移動機器。外骨骼附著在軀幹或四肢上，並使用動力關節和連桿來增加力量和耐力。外骨骼通常用於幫助人類移動並促進體力任務。智慧虛擬助理 (IVA) 是能夠理解語音命令和自然語言以協助人類完成各種任務的軟體代理。 IVA 嵌入到各種連網設備和平台中，方便、免持地擴展人類能力。虛擬實境 (VR) 設備將使用者帶入身臨其境型電腦生成的環境中。 VR 可用於遊戲、娛樂、教育、訓練、模擬等。 VR 提供的高度沉浸式體驗擴展了人類的感知、認知和身體能力。穿戴式裝置被整合到服裝和配件中以增強功能。更先進的穿戴式裝置可以提供擴增實境顯示，追蹤眼球運動和大腦活動，並增強人類的體力和耐力。

功能：更多使用穿戴式人體人類增強來增強活動能力和耐力

穿戴式人類增強包括物理連接到身體並增強身體能力的設備，例如外骨骼、穿戴式健康監視器和義肢。這些穿戴式裝置通常用於製造和醫療保健產業，以增強個人的力量、運動表現和耐力。非穿戴式人類增強包括專注於認知或感官增強的設備，包括無需物理附著即可提供功能增強的神經技術和可植入設備。這些技術不需要對身體進行物理附著，並且通常專注於認知或感官增強。

最終用戶：透過擴大人類增強技術在製造業的應用來提高工人的生產力和效率

在航太和國防領域，人類增強技術用於增強身體和認知能力，以確保卓越的性能和安全性。人類增強外裝或外骨骼可以增強士兵的體力和耐力，減少長途任務期間的疲勞，並提高機動性。在醫療保健領域，人類增強技術在復健、患者照護和改善殘障人士的生活品質方面發揮著重要作用。矯正器具人類增強義肢可提高截肢者的活動能力和生活品質。穿戴式監視器和健康追蹤設備支援慢性病管理，並向患者和醫療保健提供者提供即時健康資料。人類增強技術對於提高製造業工人的生產力、安全性和效率至關重要。外骨骼穿戴式裝置減輕了工人的身體壓力，特別是在涉及手動或重複性任務的行業中。人類增強技術在媒體和娛樂領域提供沉浸式體驗和創造性可能性。這些技術可實現身臨其境型遊戲、互動故事敘述以及豐富主題樂園和娛樂場所的體驗。

區域洞察

美洲人類增強市場在很大程度上是一個新興市場，因為本土企業專注於機器人、人工智慧和擴增實境的不斷進步。北美，特別是美國，是主要貢獻者，增加了對外骨骼、神經控制介面以及義肢和矯正器具技術的投資。該地區對醫療保健、軍事和工業領域人類賦權的關注正在推動市場擴張。由於該地區醫療保健和製造業的擴張，亞太地區人類增強市場正在顯著成長。日本和韓國等國家在開發用於醫療保健和老年護理應用的機器人外骨骼和穿戴式裝置方面處於領先地位。亞太地區市場的特點是應用多樣化，包括醫療設備和工業外骨骼，反映出人類增強技術的廣泛採用。正在進行的仿生眼研究和歐盟委員會的大量資助正在推動人們對人類增強的興趣，並且是歐洲市場成長的基礎。由於對仿生義肢以及醫療保健和復健輔助技術的投資，中東和非洲地區的人類增強市場正在成長。多樣化的應用，加上該地區的研發工作，正在為歐洲、中東和非洲地區人類增強市場的擴張做出貢獻。

FPNV定位矩陣

FPNV 定位矩陣對於評估人類增強市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對人類增強市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，以獲得市場競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.人類增強市場的市場規模和預測是多少？

2.在人類增強市場的預測期內，有哪些產品、細分市場、應用程式和領域需要考慮投資？

3.人類增強市場的技術趨勢和法規結構是什麼？

4.人類增強市場主要廠商的市場佔有率為何？

5. 進入人類增強市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 提高人們對可增強認知和身體表現的應用程式的認知和接受度
      • 醫療穿戴式裝置對人類增強的需求不斷成長
      • 航太和國防領域對手勢追蹤的需求不斷成長
    • 抑制因素
      • 開發人類增強技術的成本很高。
    • 機會
      • 繼續介紹技術先進的人類增強
      • 政府對技術開發的支持與私人投資
    • 任務
      • 由於使用人類增強技術而存在資料和個人資訊外洩的風險
  • 市場區隔分析
    • 類型：擴大擴增實境設備的使用，提供免持資料存取和導航指導
    • 功能：更多使用穿戴式人體人類增強來提高活動能力和耐力
    • 最終用戶：擴大人類增強技術在製造業的應用，以提高工人的生產力和效率
  • 市場趨勢分析
    • 美洲軍事和國防領域更多採用人類增強產品
    • 專注於亞太地區突破性人類增強技術的研發
    • 大力投資開發創新人類增強技術並擴大歐洲、中東和非洲地區在航太和國防領域的應用
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章人類增強市場：依類型

  • 擴增實境設備
  • 生物識別系統
  • 外骨骼
  • 智慧虛擬助理
  • 虛擬實境設備
  • 穿戴式裝置

第7章依功能分類的人類增強市場

  • 身體穿著
  • 非身體佩戴的

第8章人類增強市場：依最終用途分類

  • 航太和國防
  • 衛生保健
  • 製造業
  • 媒體和娛樂

第9章北美和南美的人類增強市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區人類增強市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的人類增強市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • Google和高通合作開發用於穿戴式裝置的 RISC-V 晶片
    • Vuzix 與廣達電腦簽署合作協議
    • Humane正式推出基於OpenAI的穿戴式設備“AI Pin”
    • 實現人與人之間的連結：Phantom Neuro 結合了人類增強和物聯網
    • 由 SFU 研究人員開發的 XoMotion 成為世界上最先進的外骨骼，適用於行動不便的人
    • 杜邦與意法半導體 (ST) 合作開發用於監測生物訊號的新型智慧穿戴裝置概念
    • 穿戴式裝置公司 Oura 收購數位身分Start-UpsProxy
    • 200 萬歐元資金用於新型人類增強創新，以增強人類的防禦能力
    • ARIA Research 獲得 140 萬美元津貼，在雪梨建立人類增強研究所
    • Ekso Bionics 宣布從 Parker Hannifin 公司收購人體運動與控制業務部門，包括 Indego 產品線
    • 京瓷在日本推出新的人類增強技術原型，配備先進的人工智慧以增強人類能力
    • Dasa 推出新的創新重點領域：人類增強(HA)
    • 巴黎Start-Ups籌集 4500 萬美元用於開發人類體外骨骼

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-0355904475EC

[185 Pages Report] The Human Augmentation Market size was estimated at USD 255.84 billion in 2023 and expected to reach USD 296.24 billion in 2024, at a CAGR 15.96% to reach USD 721.44 billion by 2030.

Human augmentation includes using technology and various means to improve the capabilities and attributes of the human body and mind. It involves integrating external components, such as technological devices, implants, and prosthetics, to enhance human functions, extending beyond natural human capabilities. Human augmentation technologies encompass various applications, including physical enhancements, cognitive improvements, sensory augmentations, and biohacking. Growing awareness and acceptance of cognitive and physical enhancement applications serve as catalysts for market growth. Expanding the application of human augmentation technologies in the military to enhance soldiers' physical and cognitive capabilities is driving market growth. The lack of universal standards and guidelines regarding using and applying human augmentation technologies hampers market growth. Additionally, high costs associated with research, development, and the eventual application of human augmentation technologies impede market growth. Rapid developments in fields such as robotics, artificial intelligence, and biotechnology by market vendors enable the creation of more advanced and effective human augmentation devices and solutions. They are expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 255.84 billion
Estimated Year [2024] USD 296.24 billion
Forecast Year [2030] USD 721.44 billion
CAGR (%) 15.96%

Type: Expanding usage of augmented reality devices to provide hands-free data access and navigation guidance

Augmented reality (AR) devices are wearable technologies that overlay digital information and virtual objects in the physical world. They meet the need for enhanced user experiences and productivity. These devices are in high demand due to their ability to provide hands-free data access and navigation guidance. Biometric technologies such as fingerprint/iris scanners and facial recognition systems are used for authentication and identification and are preferred for convenience and security. Biometric systems are automated methods for verifying or specifying the identity of a living person based on a physiological or behavioral characteristic. Exoskeletons are wearable mobile machines that work in conjunction with human capabilities. They fit around the torso and limbs and use powered joints and links to increase strength and endurance. Exoskeletons are often used to aid human mobility and make physical tasks easier. Intelligent virtual assistants (IVAs) are software agents that understand voice commands and natural language to assist humans with various tasks. IVAs are integrated into various internet-connected devices and platforms to augment human capabilities conveniently and hands-freely. Virtual reality (VR) devices transport users into an immersive computer-generated environment. VR is used for gaming, entertainment, education, training, and simulation. The highly immersive experience offered through VR augments human perception, cognition, and physical capabilities. Wearable devices are integrated into clothing or accessories items to enhance capabilities. More advanced wearables could provide augmented reality displays, track eye movements and brain activity, and enhance human physical strength or endurance.

Functionality: Increasing usage of body-worn human augmentation to enhance mobility and endurance

Body-worn human augmentation involves devices physically attached to the body, such as exoskeletons, wearable health monitors, and prosthetics, enhancing physical abilities. These body-worn human devices are often used in manufacturing and healthcare industries to enhance strength, mobility, and endurance of individuals. Non-body-worn human augmentation includes devices, including neurotechnology and implantable devices that provide enhancements without physical attachment, focusing on cognitive or sensory augmentation. These technologies do not require physical attachment to the body and are often focused on cognitive or sensory augmentation.

End-user: Increasing application of human augmentation technologies in the manufacturing sector to improve worker productivity and efficiency

In the aerospace & defense sector, human augmentation technologies are employed to enhance physical and cognitive abilities, ensuring superior performance and safety. Exosuits and exoskeletons human augmentation devices augment soldiers' physical strength and endurance, reducing fatigue during long missions and providing enhanced mobility. In healthcare, human augmentation technologies play a crucial role in rehabilitation, patient care, and improving the quality of life of individuals with disabilities. Prosthetic human augmentation enhances mobility and quality of life for amputees. Wearable monitors and health-tracking devices assist in managing chronic conditions and provide real-time health data for patients and healthcare providers. Human augmentation technologies are integral in the manufacturing sector to improve worker productivity, safety, and efficiency. Exoskeletons wearable devices reduce the physical strain on workers, particularly in industries involving heavy lifting or repetitive tasks. Human augmentation technologies offer immersive experiences and creative possibilities in the media & entertainment sector. These technologies enable immersive gaming, interactive storytelling, and enhanced experiences in theme parks and entertainment venues.

Regional Insights

The human augmentation market in the Americas represents a highly developing landscape due to the presence of native market players focusing on continuous advancements in robotics, artificial intelligence, and augmented reality. North America, particularly the United States, has been a key contributor, with increasing investments in exoskeletons, neural control interfaces, and prosthetic technologies. The region's focus on enhancing human capabilities in healthcare, military, and industrial sectors has spurred market expansion. The APAC human augmentation market has witnessed notable growth due to the region's expanding healthcare and manufacturing sectors. Countries such as Japan and South Korea have been at the forefront of developing robotic exoskeletons and wearable devices for healthcare and elderly care applications. APAC region's market is characterized by diverse applications, including medical devices and industrial exoskeletons, reflecting the wide adoption of human augmentation technologies. Ongoing research in bionic eye installations and considerable funding support from the European Commission underlined the growing interest in human augmentation, creating a platform for market growth in Europe. The Middle East and Africa regions human augmentation market is growing with investments in bionic limbs and assistive technologies for healthcare and rehabilitation. The diverse range of applications, coupled with the region's commitment to research and development, has contributed to expanding the human augmentation market throughout EMEA.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Human Augmentation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Human Augmentation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Human Augmentation Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Amazon.com, Inc., Apple Inc., AppliedVR, Inc., Aptima, Inc., Atheer, Inc., B-Temia Inc., Charles River Analytics, Inc., Cionic, Inc., Cognitive Mill by AIHunters, Continental AG, CYBERDYNE Inc., Ekso Bionics Holdings, Inc., Esper Bionics Inc., Fujitsu Limited, Garmin Limited, General Motors Company, Google LLC by Alphabet, Inc., HID Global Corporation by Assa Abloy AB, Hocoma AG by DIH International Limited, HTC Corporation, Hyundai Motor Company, IDEMIA Group, S.A.S., Kyocera Corporation, Lifesense Group, Magic Leap Inc., Meta Platforms, Inc., Microsoft Corporation, NEC Corporation, Nvidia Corporation, Ottobock SE & Co. KGaA, Panasonic Corporation, Parker Hannifin Corporation, Rewalk Robotics Inc., Rex Bionics Ltd, Robert Bosch GmbH, RTX Corporation, Saab AB, Samsung Electronics Co., Ltd., Soar Technology, Inc., Sony Group Corporation, Thales Group, Unity Software Inc., and Vuzix Corporation.

Market Segmentation & Coverage

This research report categorizes the Human Augmentation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Augmented Reality Device
    • Biometric System
    • Exoskeletons
    • Intelligent Virtual Assistants
    • Virtual Reality Device
    • Wearable Device
  • Functionality
    • Body Worn
    • Non-Body Worn
  • End-use
    • Aerospace & Defense
    • Healthcare
    • Manufacturing
    • Media & Entertainment
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Human Augmentation Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Human Augmentation Market?

3. What are the technology trends and regulatory frameworks in the Human Augmentation Market?

4. What is the market share of the leading vendors in the Human Augmentation Market?

5. Which modes and strategic moves are suitable for entering the Human Augmentation Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing awareness and acceptance of cognitive and physical enhancement applications
      • 5.1.1.2. Rising need for human augmentation for medical wearable devices
      • 5.1.1.3. Increasing demand from aerospace & defense for gesture-tracking purposes
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of human augmentation technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous introduction of technologically advanced human augmentation
      • 5.1.3.2. Government support and private investments for advancing human augmentation technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of data and identity breach with the usage of human augmentation technologies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Expanding usage of augmented reality devices to provide hands-free data access and navigation guidance
    • 5.2.2. Functionality: Increasing usage of body-worn human augmentation to enhance mobility and endurance
    • 5.2.3. End-user: Increasing application of human augmentation technologies in the manufacturing sector to improve worker productivity and efficiency
  • 5.3. Market Trend Analysis
    • 5.3.1. Increasing deployment of human augmentation products across military and defense of the Americas
    • 5.3.2. Emphasis on R&D for development of breakthrough human augmentation technologies in the APAC region
    • 5.3.3. Substantial investments to develop innovative human augmentation technologies and expanding applications in aerospace & defense sector in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Human Augmentation Market, by Type

  • 6.1. Introduction
  • 6.2. Augmented Reality Device
  • 6.3. Biometric System
  • 6.4. Exoskeletons
  • 6.5. Intelligent Virtual Assistants
  • 6.6. Virtual Reality Device
  • 6.7. Wearable Device

7. Human Augmentation Market, by Functionality

  • 7.1. Introduction
  • 7.2. Body Worn
  • 7.3. Non-Body Worn

8. Human Augmentation Market, by End-use

  • 8.1. Introduction
  • 8.2. Aerospace & Defense
  • 8.3. Healthcare
  • 8.4. Manufacturing
  • 8.5. Media & Entertainment

9. Americas Human Augmentation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Human Augmentation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Human Augmentation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Google and Qualcomm Partner to Make RISC-V Chip for Wearable Devices
    • 12.3.2. Vuzix Enters into a Partnership Agreement with Quanta Computer
    • 12.3.3. Humane Officially Launches the AI Pin, its OpenAI-powered Wearable
    • 12.3.4. Enabling Human Connectivity: Phantom Neuro Merges Human Augmentation and IoT
    • 12.3.5. XoMotion Created by SFU Researchers to be World's most Advanced Exoskeleton for Mobility Challenged
    • 12.3.6. DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals
    • 12.3.7. Wearable Company Oura Acquires Digital Identification Startup Proxy
    • 12.3.8. EUR 2 Million Funding for Novel Human Augmentation Innovations to Enhance Human Capability in Defense
    • 12.3.9. ARIA Research Receives USD 1.4 Million in Grant Funding to Build Human Augmentation Laboratory in Sydney
    • 12.3.10. Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego Product Line from Parker Hannifin Corporation
    • 12.3.11. KYOCERA Introduces New Human Augmentation Technology Prototypes in Japan with Advanced AI to Enhance Human Abilities
    • 12.3.12. Dasa Launches New Innovation Focus Area: Human Augmentation (HA)
    • 12.3.13. A Parisian Startup just Raised USD 45 Million to Build Human Exoskeletons

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. HUMAN AUGMENTATION MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN AUGMENTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMAN AUGMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. HUMAN AUGMENTATION MARKET DYNAMICS
  • FIGURE 7. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. HUMAN AUGMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. HUMAN AUGMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMAN AUGMENTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMAN AUGMENTATION MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN AUGMENTATION MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AUGMENTED REALITY DEVICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AUGMENTED REALITY DEVICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BIOMETRIC SYSTEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BIOMETRIC SYSTEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY EXOSKELETONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY EXOSKELETONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY INTELLIGENT VIRTUAL ASSISTANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY INTELLIGENT VIRTUAL ASSISTANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY VIRTUAL REALITY DEVICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY VIRTUAL REALITY DEVICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY WEARABLE DEVICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY WEARABLE DEVICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BODY WORN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BODY WORN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY NON-BODY WORN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY NON-BODY WORN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AEROSPACE & DEFENSE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AEROSPACE & DEFENSE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY HEALTHCARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MEDIA & ENTERTAINMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MEDIA & ENTERTAINMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 291. HUMAN AUGMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 292. HUMAN AUGMENTATION MARKET, FPNV POSITIONING MATRIX, 2023